LNA-C(5-Me)(Bz) Co-Polymer Coated CPG
Product Overview
LNA-C(5-Me)(Bz) Co-Polymer Coated CPG is an advanced, premium-grade solid support matrix engineered for automated oligonucleotide synthesis. This specialized product is optimized for the seamless incorporation of a 5-methyl-locked nucleic acid C [LNA-C(5-Me)] analogue at the 3′ end of an oligonucleotide sequence.
Featuring N⁴-benzoyl (Bz) protection on the cytidine nucleobase along with a strategic 5-methyl modification, this modified solid support allows for highly efficient chain elongation using standard DNA or RNA phosphoramidite chemistries. The incorporation of 5-Me-LNA-C residues at the 3′ terminus conformationally locks the ribose ring in a strict 3′-endo structure, drastically enhancing duplex thermal stability ΔTm. Furthermore, the 5-methyl modification significantly reduces potential immune responses in vivo while providing exceptional protection against 3′-exonucleolytic degradation, making it an indispensable tool for designing high-performance antisense oligonucleotides (ASOs), siRNA, and gapmers.
Key Technical Features & Guidelines
Advanced 5-Methyl Modification: The 5-methyl groups further stabilize the duplex architecture and mitigate immune receptor recognition compared to unmodified cytidine analogues.
Targeted 3′-End LNA Incorporation: Optimized specifically for solid-phase placement of an $N^4$-benzoyl protected 5-Me-LNA-C analogue at the 3′ terminus.
Elevated Duplex Stability: Maximizes binding affinity toward complementary RNA or DNA strands, allowing precise thermodynamic tuning of synthetic therapeutic sequences.
Advanced Co-Polymer Coating: Our proprietary crosslinked co-polymer surface chemistry eliminates silica contamination and prevents swelling, ensuring stable column pressure and reproducible fluidic flow rates under automated cycle runs.
Standardized Protection Profile: The benzoyl protection group is fully compatible with conventional downstream deprotection protocols (e.g., concentrated ammonia or AMA), fitting seamlessly into existing DNA/RNA synthesis workflows.
Flexible Pore Size Infrastructure: Available in 500 Å, 1000 Å, and 2000 Å pore sizes to comfortably accommodate both high-throughput diagnostic custom scales and heavily mass-loaded therapeutic scalability.
Applications
High-Affinity & Low-Immunogenicity Therapeutics: Fabrication of next-generation ASOs, siRNA candidates, and anti-miRNA oligonucleotides requiring minimized immune activation and robust 3′-end capping.
Thermodynamically Tuned Probes: Production of dual-labeled diagnostic probes and gapmers where precise $T_m$ control is critical.
Nuclease-Resistant Nucleic Acids: Custom engineering of oligonucleotides intended for extended stability in serum or cellular environments.
Synthesis Optimization Note (Hyper-link CPG Benefits)
Our LNA-C(5-Me)(Bz) CPG product line leverages our proprietary co-polymer coated matrix technology (Hyper-link CPG), which is available for all kinds of tailored linkers. This structural integration unlocks measurable benefits for industrial scale-up:
3× Higher Output & Lower COG: Our Hyper-link CPG delivers up to a 3× higher loading capacity compared to traditional corresponding un-coated supports, allowing laboratories to drastically lower their overall Cost of Goods (COG).
~30% Lower Purification Costs: Delivers exceptional Full-Length Product (FLP) purity straight out of the synthesis column, optimizing downstream chromatographic workflows.
Reliable Long-Oligo Synthesis: Engineered to sustain high coupling efficiency for complex or extended sequences (100–300 nt) with zero structural collapse.
We supply this product as a standalone, high-performance solid support matrix in multiple bulk configurations to meet your specific research and commercial production scales.
Related Products:
LNA-G(dmf) Co-Polymer Coated CPG






Reviews
There are no reviews yet.